PTC Therapeutics PTCT Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's investing cash flow?
- PTC Therapeutics (PTCT) reported investing cash flow of -$93.74M in Q1 2026.
- How has PTC Therapeutics's investing cash flow changed year-over-year?
- PTC Therapeutics's investing cash flow increased by 49.2% year-over-year, from -$184.36M to -$93.74M.
- What is the long-term trend for PTC Therapeutics's investing cash flow?
- Over 4 years (2021 to 2025), PTC Therapeutics's investing cash flow has grown at a 42.2% compound annual growth rate (CAGR), from $219.18M to -$895.99M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.